Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1998
03/05/1998CA2264101A1 Preventives/remedies for muscle tissue degenerations
03/05/1998CA2264080A1 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht1a ligands
03/05/1998CA2264078A1 4-aminoethoxy indolone derivatives
03/05/1998CA2264072A1 4-aminoethoxy-indolone derivatives as dopamine d2 agonists
03/05/1998CA2264045A1 Heterocyclic metalloprotease inhibitors
03/05/1998CA2264044A1 Spirocyclic metalloprotease inhibitors
03/05/1998CA2264020A1 Inhibitors of phospholipase enzymes
03/05/1998CA2263999A1 Integrin antagonists
03/05/1998CA2263998A1 Compositions and methods for administering integrin receptor antagonists
03/05/1998CA2263978A1 Enhanced stimulation of erythropoiesis
03/05/1998CA2263951A1 Use of a mutated macrolide binding protein for the prevention of gvhd
03/05/1998CA2263932A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998CA2263928A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998CA2263917A1 Heterocyclic metalloprotease inhibitors
03/05/1998CA2263914A1 Bidentate metalloprotease inhibitors
03/05/1998CA2263907A1 Nonclassical pyrrolo[2,3-d]pyrimidine antifolates
03/05/1998CA2263885A1 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998CA2263839A1 Use of arachidonic acid and/or docosahexanoic acid for the manufacture of a medicament for the treatment of dyspraxia
03/05/1998CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use
03/05/1998CA2263826A1 Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor
03/05/1998CA2263817A1 Therapeutic combinations of rar antagonists and rxr agonists and use thereof
03/05/1998CA2263499A1 Use of inhibitors of pkc for the manufacture of a medicament for the treatment of central nervous system diseases associated with hiv infection
03/05/1998CA2263420A1 Pharmaceutical compounds
03/05/1998CA2263175A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/05/1998CA2263161A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of htlv-1 infections
03/05/1998CA2263133A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of aids
03/05/1998CA2262708A1 Manipulations of nitrosative and oxidatives stress in the treatment of disease
03/05/1998CA2259151A1 Enzyme and dna sequence encoding same
03/05/1998CA2194256A1 Ikaros: a t cell pathway regulatory gene
03/04/1998EP0826687A1 Carbapenem derivatives and antimicrobial agents comprising the same
03/04/1998EP0826685A1 Stable, long acting salts of carboxamides for the treatment of joint disease
03/04/1998EP0826683A1 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods
03/04/1998EP0826682A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/04/1998EP0826680A1 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods
03/04/1998EP0826679A2 Naphthyl compounds, intermediates, compositions, and method of use
03/04/1998EP0826676A1 Oxazole derivatives and use thereof
03/04/1998EP0826673A1 Acetamide derivatives, process for producing the same, and medicinal composition containing the same
03/04/1998EP0826670A1 Naphthalene compounds, intermediates, formulations, and methods
03/04/1998EP0826668A1 Derivatives of 2-imino-2,3-dihydro-1H-indole and their use in hair dyeing compositions
03/04/1998EP0826663A2 Alkynylamino acid derivatives and their use as pharmaceutical compounds
03/04/1998EP0826657A1 Compounds for modulation of hormone receptors, compositions containing them and their use in therapy
03/04/1998EP0826371A1 External preparation containing emedastine
03/04/1998EP0826370A1 Pharmaceutical composition comprising 2-phenyl-1,2-benzoisoelenazol-3(2H)-one for the treatment of Alzheimer disease
03/04/1998EP0826369A1 Therapeutic use of dioxabicyclo (3.3.0)octane compounds
03/04/1998EP0826368A1 Use of retinoids for the preparation of a medicament for treating disorders related to VEGF overexpression
03/04/1998EP0826365A2 Tocopheryl ascorbyl phosphate-cyclodextrin clathrate and a topical dermal composition containing said clathrate
03/04/1998EP0826303A1 A method of preventing animals from diseases and improving immune function of animals
03/04/1998EP0826063A1 Single-vial formulations of dna/lipid complexes
03/04/1998EP0826048A1 Pancreas-derived serpin
03/04/1998EP0826045A1 Nucleic acids for treating obesity
03/04/1998EP0826043A1 Methods for modulating t cell survival by modulating bcl-x l? protein level
03/04/1998EP0826042A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
03/04/1998EP0826041A1 Transforming growth factor alpha hii
03/04/1998EP0825996A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
03/04/1998EP0825995A1 Antibiotics
03/04/1998EP0825994A1 Amidine derivatives useful as anti-platelet aggregation inhibitors and vasodilators
03/04/1998EP0825993A1 Xanthines and their therapeutic use
03/04/1998EP0825991A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
03/04/1998EP0825989A1 Substituted oxazoles for the treatment of inflammation
03/04/1998EP0825986A1 Quinolyl-ethynyl derivatives having retinoid-like activity
03/04/1998EP0825984A1 Novel method
03/04/1998EP0825983A1 Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives
03/04/1998EP0825981A1 Novel heterocyclic compounds
03/04/1998EP0825980A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylakenyl derivatives as therapeutic agents for the treatment of ocular hypertension
03/04/1998EP0825972A1 Novel ether compound and process for producing the same
03/04/1998EP0825885A1 Pulmonary delivery of aerosolized medicaments
03/04/1998EP0825877A1 Method and composition for prevention of posterior capsule opacification
03/04/1998EP0825871A1 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
03/04/1998EP0825869A1 Pharmaceutical composition comprising lactobacillus plantarum and arginine
03/04/1998EP0825867A1 N,o-carboxymethylchitosan for prevention of surgical adhesions
03/04/1998EP0825866A1 Combined preparations with vascular effect containing dihydropyridines, acetylsalicylic acid nitroesters and vitamins
03/04/1998EP0825865A1 Transdermal therapeutic system for administering testosterone
03/04/1998EP0825864A1 Anti-emetic pharmaceutical compositions containing methotrimeprazine
03/04/1998EP0825863A1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
03/04/1998EP0825862A1 Use of(s)-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
03/04/1998EP0825861A1 High-dose chromic tripicolinate for the treatment of type ii diabetes
03/04/1998EP0825860A1 Composition comprising amoxycillin and clavulanic acid
03/04/1998EP0825859A1 Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
03/04/1998EP0825858A1 Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
03/04/1998EP0825857A1 A method of treatment of mania and bipolar disorder
03/04/1998EP0825856A1 Irritation relief using nonsteroidal anti-inflammatory compounds
03/04/1998EP0825855A1 Agents for reducing weight
03/04/1998EP0825854A1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
03/04/1998EP0825853A1 Prolonged nerve blockage by the combination of local anesthetics and glucocorticoids
03/04/1998EP0825851A1 Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof
03/04/1998EP0825848A1 Novel collagen formulations
03/04/1998EP0794783A4 Cyclodextrins as suspending agents for pharmaceutical suspensions
03/04/1998EP0731992A4 High-density interconnect technique
03/04/1998EP0711156A4 Use of n-methyl-aspartic acid for enhancing growth and altering body composition
03/04/1998EP0700293B1 Dihydrotestosterone for use in androgenotherapy
03/04/1998EP0692962B1 Use of steroid antagonists for the therapy and prophylaxis of demential illnesses
03/04/1998EP0670047B1 Functional radar warning receiver back-up generator
03/04/1998EP0617614B1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
03/04/1998EP0616523B1 Medicaments
03/04/1998EP0487632B1 Stabilized vaccine compositions
03/04/1998CN1175259A Low molecular weight bicyclic thrombin inhibitors
03/04/1998CN1175258A Thienoxazinone derivatives useful as antiviral agents
03/04/1998CN1175256A Tetracyclic spiro compounds, process for their preparation and their use as 5 HT1D receptor antagonists
03/04/1998CN1175254A Piperidineacetic acid derivatives useful as fibrinogen antagonist agent
03/04/1998CN1175253A Piperazine 2, 5 dione derivatives as modulators of multi-drug resistance
1 ... 6683 6684 6685 6686 6687 6688 6689 6690 6691 6692 6693 6694 6695 6696 6697 6698 6699 6700 6701 6702 6703 ... 7860